Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.
Brain Behav Immun Health
; 22: 100463, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1800191
ABSTRACT
Vaccination is an essential public health strategy to control the 2019 Coronavirus (COVID-19) pandemic. While the benefits of the COVID-19 vaccines far outweigh the risks, side effects continue to be reported in the literature. We report a 65-year-old man who developed cognitive deficits and memory impairments following his first dose of Oxford AstraZeneca vaccine (Covishield). The onset of acute cognitive deficits and memory impairments could be another complication to COVID-19 vaccination that physicians and neurologists need to be warned to. Monitoring the safety of COVID-19 vaccines and describing side effects associated with them is essential to improve safety profiles and enhance public trust.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Brain Behav Immun Health
Year:
2022
Document Type:
Article
Affiliation country:
J.bbih.2022.100463
Similar
MEDLINE
...
LILACS
LIS